154 related articles for article (PubMed ID: 38207154)
1. The Operative Link on Gastritis Assessment (OLGA) system as a marker for gastric cancer and dysplasia in a Colombian population at risk: A multicenter study.
Carlosama YH; Acosta CP; Sierra CH; Rosero CY; Bolaños HJ
Biomedica; 2023 Dec; 43(Sp. 3):30-40. PubMed ID: 38207154
[TBL] [Abstract][Full Text] [Related]
2. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
[TBL] [Abstract][Full Text] [Related]
3. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
[TBL] [Abstract][Full Text] [Related]
4. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
5. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
[TBL] [Abstract][Full Text] [Related]
6. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
7. OLGA- and OLGIM-Based Staging in the Patients with Gastritis and Endoscopy Indications.
Mansour-Ghanaei F; Joukar F; Yeganeh S; Sadeghi M; Daryakar A; Sepehrimanesh M
Turk J Gastroenterol; 2022 Feb; 33(2):95-102. PubMed ID: 35238779
[TBL] [Abstract][Full Text] [Related]
8. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
[TBL] [Abstract][Full Text] [Related]
9. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
[TBL] [Abstract][Full Text] [Related]
10. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
Ogutmen Koc D; Bektas S
Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
[TBL] [Abstract][Full Text] [Related]
12. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
Na YS; Kim SG; Cho SJ
Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
[TBL] [Abstract][Full Text] [Related]
13. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
14. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.
Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J
Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492
[TBL] [Abstract][Full Text] [Related]
15. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
[TBL] [Abstract][Full Text] [Related]
16. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study.
Rugge M; de Boni M; Pennelli G; de Bona M; Giacomelli L; Fassan M; Basso D; Plebani M; Graham DY
Aliment Pharmacol Ther; 2010 May; 31(10):1104-11. PubMed ID: 20180784
[TBL] [Abstract][Full Text] [Related]
17. OLGA gastritis staging in young adults and country-specific gastric cancer risk.
Rugge M; Kim JG; Mahachai V; Miehlke S; Pennelli G; Russo VM; Perng CL; Chang FY; Tandon RK; Singal DK; Sung JJ; Valenzuela JE; Realdi G; Dore MP; Graham DY
Int J Surg Pathol; 2008 Apr; 16(2):150-4. PubMed ID: 18417671
[TBL] [Abstract][Full Text] [Related]
18. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.
Salazar BE; Pérez-Cala T; Gomez-Villegas SI; Cardona-Zapata L; Pazos-Bastidas S; Cardona-Estepa A; Vélez-Gómez DE; Justinico-Castro JA; Bernal-Cobo A; Dávila-Giraldo HA; Benítez-Guerra JC; Valencia-Cárdenas JT; Ospina EJ; Castaño-Llano R; Bravo MM; Cataño-Correa JC; Zabaleta J; Trespalacios-Rangel AA; Cock-Botero AM; Roldán-Pérez MI; Martínez A
Virchows Arch; 2022 Apr; 480(4):759-769. PubMed ID: 35089403
[TBL] [Abstract][Full Text] [Related]
19. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
Rugge M; Genta RM; Fassan M; Valentini E; Coati I; Guzzinati S; Savarino E; Zorzi M; Farinati F; Malfertheiner P
Am J Gastroenterol; 2018 Nov; 113(11):1621-1628. PubMed ID: 30333540
[TBL] [Abstract][Full Text] [Related]
20. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer.
Tsai YC; Hsiao WH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS
Aliment Pharmacol Ther; 2013 May; 37(10):969-78. PubMed ID: 23550594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
